Addex Therapeutics (ADXN) Exchange Rate Effect (2019 - 2025)
Addex Therapeutics' (ADXN) quarterly Exchange Rate Effect came in at -$38839.7 in Q2 2025, up 100.0% year-on-year from -$19419.9 in Q2 2024, and down 26961.48% quarter-over-quarter from $144.59 in Q1 2025.
Addex Therapeutics (ADXN) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Addex Therapeutics has disclosed Exchange Rate Effect across 7 years of filings, most recently posting -$38839.7 for Q2 2025.
- Exchange Rate Effect for Q2 2025 came in at -$38839.7, up 100.0% year-over-year; the trailing twelve-month figure through Jun 2025 was $836.4 million (down 99.52% YoY), and the FY2025 annual result was -$42438.8, down 137.3% from the prior year.
- Exchange Rate Effect came in at -$38839.7 for Q2 2025 at Addex Therapeutics, down from $144.59 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $170.1 billion in Q4 2023 to a low of -$108.4 billion in Q2 2024.
- The 5-year median for Exchange Rate Effect is -$151.27 (2022), against an average of $9.7 billion.
- Peak annual rise in Exchange Rate Effect reached 128195970463.36% in 2024, while the deepest fall reached 9951848046.56% in 2024.
- Addex Therapeutics' Exchange Rate Effect stood at -$204783.3 in 2021, then advanced by 0.42% to -$203920.4 in 2022, then jumped by 83425168.87% to $170.1 billion in 2023, then plunged by 144.25% to -$75.3 billion in 2024, then soared by 100.0% to -$38839.7 in 2025.
- The last three Exchange Rate Effect figures came in at -$38839.7 (Q2 2025), $144.59 (Q1 2025), and -$75.3 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | Addex Therapeutics | 1.08 Bn | 1.08 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -38,839.71 |
| Jun 30, 2025 | -38,839.71 |
| Mar 31, 2025 | 144.59 |
| Mar 31, 2025 | 144.59 |
| Dec 31, 2024 | -75.27 Bn |
| Dec 31, 2024 | -75.27 Bn |
| Sep 30, 2024 | 76.11 Bn |
| Sep 30, 2024 | 76.11 Bn |
| Jun 30, 2024 | -108.36 Bn |
| Jun 30, 2024 | -108.36 Bn |
| Mar 31, 2024 | 112.27 Bn |
| Mar 31, 2024 | 112.27 Bn |
| Dec 31, 2023 | 170.12 Bn |
| Dec 31, 2023 | 170.12 Bn |
| Sep 30, 2023 | -293.23 |
| Sep 30, 2023 | -293.23 |
| Jun 30, 2023 | -1,088.82 |
| Jun 30, 2023 | -1,088.82 |
| Mar 31, 2023 | 87.57 |
| Mar 31, 2023 | 87.57 |